Insulet | Créances Commerciales



Trade Debtors Changement Date
Abbott USD 7.05B 197M 2024-09
Align Technology USD 1.03B 129.79M 2024-12
AtriCure USD 60.34M 5.43M 2024-12
Avanos Medical USD 132.8M 900K 2024-12
Baxter International USD 1.73B 53M 2024-12
Becton, Dickinson and Co. USD 2.64B 395M 2024-12
Boston Scientific USD 2.56B 57M 2024-12
Cardinal Health USD 12.37B 588M 2024-12
Cooper Companies USD 716.4M 600K 2025-01
Dexcom USD 1.03B 100K 2024-12
Edwards Lifesciences USD 727.4M 84.1M 2024-12
Eli Lilly USD 13.28B 1.22B 2024-12
Globus Medical USD 578.33M 14.87M 2024-12
ICU Medical USD 187.27M 9.55M 2024-12
Insulet USD 365.5M 10.1M 2024-12
Integra LifeSciences USD 272.37M 16.24M 2024-12
J&J USD 14.84B 1.33B 2024-12
Masimo USD 489.3M 44.7M 2024-12
Medtronic USD 6.12B 145M 2025-01
Merit Medical Systems USD 209.17M 4.18M 2024-12
Roche Holding CHF 13.46B 984M 2024-12
Solventum Corp 1.23B 98M 2024-12
Stryker USD 3.99B 251M 2024-12
Tandem Diabetes Care USD 114.58M 7.4M 2024-12
Teleflex USD 459.5M 10.76M 2024-12
West Pharmaceutical Services USD 552.5M 28.2M 2024-12
Zimmer Biomet Holdings USD 1.48B 800K 2024-12



Insulet Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.